Results 61 to 70 of about 638,962 (313)

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani   +9 more
wiley   +1 more source

ROC-analysis (HCC vs. hepatitis and cirrhosis).

open access: yes, 2017
ROC-analysis (HCC vs. hepatitis and cirrhosis).
Per Stål (2219593)   +7 more
core   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Knee or ROC

open access: yes
Self-attention transformers have demonstrated accuracy for image classification with smaller data sets. However, a limitation is that tests to-date are based upon single class image detection with known representation of image populations. For instances where the input image classes may be greater than one and test sets that lack full information on ...
Wendt, Veronica   +4 more
openaire   +4 more sources

ROC-curves Schmidt & Witte 1978 test data.

open access: yes, 2019
ROC-curves Schmidt & Witte 1978 test data.
Nikolaj Tollenaar (6439550)   +1 more
core   +1 more source

ROC-AUC curve, false positive rate-threshold curve and precision-recall curve for ten ESM RF models.

open access: yes, 2023
a) ROC-AUC curve. b) False positive rate-threahold curve. c) Precision-recall curve.
Li Xie (108913), Lei Xie (61344)
core   +1 more source

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso   +5 more
wiley   +1 more source

Tumour‐proximal deep serum proteomics identifies biomarkers associated with ovarian cancer

open access: yesMolecular Oncology, EarlyView.
New biomarkers are needed for early ovarian cancer detection. Ovarian (tumour‐proximal) and peripheral vein serum from healthy women and patients with benign or malignant tumours underwent nanoparticle‐enriched deep proteomics. Ovarian serum yielded more protein identifications and revealed tumour‐reflective signatures.
Darren Lau   +9 more
wiley   +1 more source

ROC-curves for volumetric determinants.

open access: yes, 2017
Five-fold cross-validated (CV) ROC-curves for either changes in absolute volume (delta) or regional volume subtractions (sub) for the prediction of disease progression.
Tobias Boeckh-Behrens (436855)   +11 more
core   +1 more source

The impact of leukocyte‐associated RNA retention on platelet RNA‐based cancer detection

open access: yesMolecular Oncology, EarlyView.
Platelets carry RNA signals that may help detect cancer, but platelet samples can also retain RNA from white blood cells. We found that this retained white blood cell signal did not significantly affect machine learning cancer classification, suggesting that the cancer‐related RNA signal in platelets is largely independent of leukocyte‐associated RNA ...
Michał Sieczczyński   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy